A Novel MSE Score to Predict rHCC Patients

NCT05450874 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2022-07-11

No results posted yet for this study

Summary

Develop and validate a novel scoring system based on pathological factors to predict the postoperative survival of patients with rHCC.Patients with rHCC who underwent hepatectomy were recruited from two hospitals.Exploring whether this scoring system is related to prognosis

Conditions

Interventions

PROCEDURE

hepatectomy

Sponsors & Collaborators

  • Tongji Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-01
Primary Completion
2017-03-01
Completion
2022-06-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05450874 on ClinicalTrials.gov